HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation.

AbstractBACKGROUND:
In the 1990s, partial stomach-partitioning gastrojejunostomy (PSPG) was introduced. Benefits of this method are that it preferentially shunts food away from the obstructed duodenum or pylorus, thus reducing reflex emesis.
METHODS:
A retrospective review of patients undergoing PSPG for malignant obstruction from 1999 to 2011 was performed. Ability to tolerate oral intake in the postoperative period and at last follow-up was the criterion for a successful bypass.
RESULTS:
Fifty-five patients with locally advanced or metastatic tumors underwent PSPG. The median follow-up period was 8 months. No patient developed signs of gastric outlet obstruction after PSPG. Seventy-five percent of patients had pancreatic or duodenal and 25% had nonpancreatic cancers. Nine patients developed postoperative complications. The perioperative mortality rate was zero. Median overall survival was 9 months. All patients were tolerating an enteral diet on the day of discharge, and as of the last follow-up, 95% were tolerating their enteral diets.
CONCLUSIONS:
This and a previous study from the authors' institution show that PSPG is a good alternative for palliative bypass in the setting of malignant gastric outlet obstruction over classic gastrojejunostomy.
AuthorsRodrigo Arrangoiz, Pavlos Papavasiliou, Smit Singla, Veeraiah Siripurapu, Tianyu Li, James C Watson, John P Hoffman, Jeffrey M Farma
JournalAmerican journal of surgery (Am J Surg) Vol. 206 Issue 3 Pg. 333-9 (Sep 2013) ISSN: 1879-1883 [Electronic] United States
PMID23706260 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Duodenal Obstruction (pathology, surgery)
  • Female
  • Gastric Bypass (methods)
  • Gastric Outlet Obstruction (pathology, surgery)
  • Gastrointestinal Neoplasms (pathology, surgery)
  • Humans
  • Male
  • Middle Aged
  • Palliative Care
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: